Lactulose Solution
Product Images NDC 61037-471

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Lactulose Solution (NDC 61037-471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bajaj Medical, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

118ml1 (118ml 1)

Lactulose Solution, USP 10 g/15 mL oral and rectal solution label from Bajaj Medical, LLC. The label includes product strength, dosing form, storage instructions, and manufacturer address, with a 4 oz. (118 mL) bottle size indicated. It features dosage details, pharmacist instructions, and a barcode.*

FDA Label Image

118ml2 (118ml 2)

Prescribing information for Lactulose Solution USP 10 g/15 mL includes usage for oral or rectal administration to prevent and treat portal-systemic encephalopathy. The panel details the chemical structure of lactulose, the pharmacological effects, including its action on ammonia levels, and clinical indications for reducing blood ammonia and improving patient symptoms.*

FDA Label Image

118ml3 (118ml 3)

A text panel containing warnings, contraindications, precautions, drug interactions, and pregnancy and nursing mother information for Lactulose Solution USP 10 g/15 mL. It includes details about theoretical hazards, contraindications for patients needing a low galactose diet, and notes on the safety of use in special populations such as infants and pregnant women.*

FDA Label Image

118ml4 (118ml 4)

Text panel from Lactulose Solution USP, 10 g/15 mL, detailing warnings related to pediatric use and nursing mothers, adverse reactions, overdose signs and symptoms, and partially showing dosage and administration instructions for oral and rectal use. The text covers dosing guidance for adults, pediatrics, and patients with portal-systemic encephalopathy.*

FDA Label Image

118ml5 (118ml 5)

Lactulose Solution, USP 10 g/15 mL oral and rectal solution label from Bajaj Medical, LLC. The label includes product identifier NDC 61037-471-13 and directions for use. It states the solution is clear yellow to golden-yellow, supplied in various amber and white plastic bottles with child-resistant closures. Storage instructions specify controlled room temperature 20-25°C (68-77°F) and to keep the container tightly closed. The 4-ounce (118 mL) size is indicated.*

FDA Label Image

15ml1 (15ml 1)

The image displays the packaging label for Lactulose Solution USP 10 g/15 mL by Bajaj Medical, LLC. It features dosing information indicating 100 unit dose cups, each delivering 15 mL. The label includes storage instructions, a barcode, and notes that the product is for oral or rectal administration and is Rx only.*

FDA Label Image

15ml2 (15ml 2)

Prescribing information for Lactulose Solution USP 10 g/15 mL presenting detailed clinical pharmacology, indications, contraindications, warnings, precautions, drug interactions, and reproductive safety information. The panel includes a chemical structural formula of lactulose and explanations of its action, usage for portal-systemic encephalopathy, and cautions on use during pregnancy and nursing.*

FDA Label Image

15ml3 (15ml 3)

The image shows a detailed drug facts label for Lactulose Solution USP 10 g/15 mL by Bajaj Medical, LLC. It includes dosing and administration instructions for oral and rectal use, adverse reactions, overdose information, storage conditions, and pharmacist dispensing information. The label highlights that the solution is supplied in unit dose cups of 15 mL and notes temperature guidelines and shelf storage advice.*

FDA Label Image

1893ml1 (1893ml 1)

Label for Lactulose Solution USP 10 g/15 mL by Bajaj Medical, LLC. The label indicates the product is for oral or rectal administration, supplied in a 64 fl oz (1893 mL) bottle, and is Rx only. It includes usage instructions, storage conditions, manufacturer details, a barcode, and a yellow area marked 'Datalase Imprint Area.'*

FDA Label Image

1893ml2 (1893ml 2)

Prescribing information for Lactulose Solution USP 10 g/15 mL details its use for oral or rectal administration in preventing and treating portal-systemic encephalopathy. The label includes a chemical structure, clinical pharmacology, indications, contraindications, warnings, precautions, drug interactions, carcinogenicity, pregnancy, and nursing mothers information.*

FDA Label Image

1893ml3 (1893ml 3)

This text panel contains detailed prescribing information for Lactulose Solution USP, 10 g/15 mL, including pediatric use, adverse reactions, overdose symptoms, dosage and administration guidelines for oral and rectal routes, and storage instructions. It also provides manufacturing and packaging details by Bajaj Medical, LLC.*

FDA Label Image

236ml1 (236ml 1)

Label for Lactulose Solution USP 10 g/15 mL, an oral and rectal solution by Bajaj Medical, LLC. The label shows the product name, strength, NDC 61037-471-02, Rx only designation, storage instructions (20-25°C), and manufacturer address in Chicago, IL. It includes a barcode and detailed text on contents and handling.*

FDA Label Image

236ml2 (236ml 2)

Prescribing Information for Lactulose Solution USP 10 g/15 mL for oral or rectal administration. The text details drug description, chemical structure formula, clinical pharmacology explaining how lactulose reduces blood ammonia, and indications for preventing and treating portal-systemic encephalopathy, including stages of hepatic pre-coma and coma.*

FDA Label Image

236ml3 (236ml 3)

A multi-column text panel containing safety information for Lactulose Solution, 10 g/15 mL. The panel includes sections on contraindications, warnings about gas accumulation and procedures, precautions for diabetic patients, drug interactions, and notes on pregnancy and nursing mothers. It also discusses risks like hyponatremia, dehydration, and possible carcinogenicity risks with detailed cautionary statements.*

FDA Label Image

236ml4 (236ml 4)

This text panel provides detailed information on Lactulose Solution USP, 10 g/15 mL, including pediatric use caution, adverse reactions such as gas production and diarrhea, overdose symptoms and recommendations, and detailed dosage and administration instructions for oral and rectal routes. It covers dosing guidelines for adults, children, and infants, as well as instructions for enema preparation and use in portal-systemic encephalopathy.*

FDA Label Image

236ml5 (236ml 5)

Label for Lactulose Solution USP 10 g/15 mL, an oral and rectal solution. The label includes the product name, strength, administration route, storage instructions (store at 20-25°C, do not freeze), and manufacturer information (Bajaj Medical, LLC, Chicago, IL). It also details container types and contents per tablespoon, with a barcode and NDC 61037-471-02 visible.*

FDA Label Image

30ml1 (30ml 1)

Lactulose Solution USP 10 g/15 mL label for oral or rectal administration by Bajaj Medical, LLC. The label specifies 100 cups, each delivering 30 mL. It includes storage instructions, pharmacist dispensing directions, and manufacturing information at 415 W Pershing Rd, Chicago, IL. The label features a barcode and a yellow imprint area.*

FDA Label Image

30ml2 (30ml 2)

A prescribing information panel for Lactulose Solution USP 10 g/15 mL. It includes sections on description, clinical pharmacology, indications and usage, contraindications, warnings, precautions, drug interactions, carcinogenesis, pregnancy, and nursing mothers. The text details the chemical structure of lactulose and pharmacological effects relevant to oral or rectal administration for portal-systemic encephalopathy treatment.*

FDA Label Image

30ml3 (30ml 3)

Drug facts and directions for Lactulose Solution USP 10 g/15 mL by Bajaj Medical, LLC, showing dosage, administration, adverse reactions, overdose information, and storage instructions. It includes oral and rectal use guidelines, pediatric use notes, and details about the solution color, container types, and pharmacist dispensing instructions. The label emphasizes storage at controlled room temperature and advises keeping the container tightly closed.*

FDA Label Image

3785ml1 (3785ml 1)

Label for Lactulose Solution USP 10 g/15 mL oral and rectal solution by Bajaj Medical, LLC. The label includes the NDC 61037-471-06 with a 128 fl oz (3785 mL) bottle size. It shows dosing information, storage instructions, barcode, and manufacturer details. The label also features a designated imprint area.*

FDA Label Image

3785ml2 (3785ml 2)

The image shows the prescribing information for Lactulose Solution USP 10 g/15 mL. It includes detailed sections on drug description, chemical structure, clinical pharmacology, indications and usage, contraindications, warnings, precautions, drug interactions, carcinogenesis, pregnancy, and nursing mothers. The text covers use for prevention and treatment of portal-systemic encephalopathy via oral or rectal administration.*

FDA Label Image

3785ml3 (3785ml 3)

Label panel for Lactulose Solution, USP 10 g/15 mL by Bajaj Medical, LLC. The panel details indications, dosage, and administration instructions for oral or rectal use, including warnings about adverse reactions, overdose, and storage conditions. It also includes container descriptions and instructions for both adult and pediatric use, emphasizing tight, light-resistant containers and controlled room temperature storage.*

FDA Label Image

473ml1 (473ml 1)

Label for Lactulose Solution, USP 10 g/15 mL oral and rectal solution by Bajaj Medical, LLC. The label includes NDC 61037-471-12 and specifies a 16 fl oz (473 mL) bottle. It lists administration routes, storage instructions, manufacturer address, barcode, and Rx Only designation.*

FDA Label Image

473ml2 (473ml 2)

Prescribing information panel for Lactulose Solution USP 10 g/15 mL details its use for oral or rectal administration in treating portal-systemic encephalopathy. The panel includes description, chemical structure, clinical pharmacology, indications and usage, contraindications, warnings, precautions, drug interactions, carcinogenesis data, and pregnancy and nursing information.*

FDA Label Image

473ml3 (473ml 3)

Drug Facts panel for Lactulose Solution USP 10 g/15 mL by Bajaj Medical, LLC. Includes details on pediatric use, adverse reactions, overdose signs, oral and rectal dosage and administration, storage instructions at 20-25°C, and pharmacist dispensing requirements. The panel covers indications, composition, pH range, and packaging information for a 16 fl oz (473 mL) solution for oral or rectal use, prescription only.*

FDA Label Image

946ml1 (946ml 1)

Label for Lactulose Solution USP 10 g/15 mL, a 32 fl oz (946 mL) oral and rectal solution by Bajaj Medical, LLC. The label includes the NDC 61037-471-03, storage instructions, and details about the contents and administration. The label features a barcode and a yellow section marked 'Datalase Imprint Area'.*

FDA Label Image

946ml2 (946ml 2)

This image displays the prescribing information for Lactulose Solution USP 10 g/15 mL, intended for oral or rectal administration for prevention and treatment of portal-systemic encephalopathy. It includes a detailed description, clinical pharmacology with a structural formula of lactulose, indications and usage, contraindications, warnings, precautions, potential drug interactions, carcinogenicity, pregnancy and nursing mother considerations.*

FDA Label Image

946ml3 (946ml 3)

Drug facts and administration instructions for Lactulose Solution USP 10 g/15 mL, including pediatric use, adverse reactions, overdose information, oral and rectal dosage and administration, storage instructions, and manufacturer details by Bajaj Medical, LLC. The text details dosage adjustments, handling, and preparation guidance for use in adults and pediatric patients with portal-systemic encephalopathy.*

FDA Label Image

Struct (Struct)

Chemical structure diagram of lactulose, showing its molecular arrangement with hydroxyl groups and ring structures typical of this disaccharide sugar.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.